Forty three Eighteen Advisors LLC Invests $2 Million in National Health Investors, Inc. $NHI

Forty three Eighteen Advisors LLC acquired a new stake in National Health Investors, Inc. (NYSE:NHI) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 24,791 shares of the real estate investment trust’s stock, valued at approximately $2,005,000. National Health Investors accounts for 1.5% of Forty three Eighteen Advisors LLC’s portfolio, making the stock its 18th biggest holding.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Renaissance Group LLC raised its stake in National Health Investors by 3.8% during the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock valued at $245,000 after purchasing an additional 117 shares during the last quarter. GAMMA Investing LLC grew its position in National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 136 shares during the last quarter. Captrust Financial Advisors grew its position in National Health Investors by 1.7% in the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after purchasing an additional 146 shares during the last quarter. Assetmark Inc. increased its holdings in shares of National Health Investors by 13.5% during the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust’s stock worth $110,000 after purchasing an additional 161 shares during the period. Finally, Inspire Investing LLC increased its holdings in shares of National Health Investors by 3.2% during the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust’s stock worth $510,000 after purchasing an additional 198 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

Insider Transactions at National Health Investors

In other National Health Investors news, CEO D. Eric Mendelsohn purchased 1,500 shares of the business’s stock in a transaction on Friday, June 5th. The stock was purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the business’s stock in a transaction on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 2.70% of the company’s stock.

National Health Investors Trading Up 0.8%

Shares of National Health Investors stock opened at $79.76 on Friday. The firm has a market capitalization of $3.87 billion, a PE ratio of 25.73, a price-to-earnings-growth ratio of 3.55 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The company’s fifty day moving average price is $74.45 and its two-hundred day moving average price is $79.60. National Health Investors, Inc. has a 52-week low of $67.94 and a 52-week high of $91.38.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is 118.71%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on NHI. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Deutsche Bank Aktiengesellschaft lowered their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Finally, Truist Financial reduced their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and a consensus price target of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.